T-46 Is skin toxicity a predictor of better survival of patients with HCC treated with sorafenib?
A. De Santis, C. Iegri, S. Trapani, M. Lupo, F. Giubilo, C. Bassanelli, F. Attili, G. Gallusi, A.F. AttiliVolume:
44
Year:
2012
Language:
english
DOI:
10.1016/s1590-8658(12)60083-8
File:
PDF, 229 KB
english, 2012